Navigation Links
New Micro-Bland Embolization Technique with Embozene(TM) Microspheres to Be Presented at the International Medical Conference in Lisbon, Portugal
Date:9/16/2009

NEWNAN, Ga., Sept. 16 /PRNewswire/ -- CeloNova BioSciences, Inc. today announced that Franco Orsi, MD, PhD, will make two presentations at the Cardiovascular and Interventional Radiology Society of Europe (CIRSE) conference about "micro-bland embolization" which has demonstrated excellent clinical results in treating liver cancer. Professor Orsi and his colleagues at the European Institute of Oncology in Milan, Italy have developed a technique to cut off the blood supply inside liver tumors and liver metastases that leads to effective tumor control and reduced recurrence of tumors without the use of chemotherapy drugs.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090916/CL76973)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081001/CLW080LOGO-b)

"Embolic particles should be size-calibrated with a small bandwidth in diameter variations because during administration, larger particles within the same vial or syringe may occlude micro-vessels more proximally and prevent a deeper penetration of the smaller ones," reports Professor Orsi, whose findings will be presented at the CIRSE medical conference September 19-23 and published in the September edition of Vascular Disease Management.

"We are gratified that Dr. Orsi has developed this micro-bland embolization technique and demonstrated that the unique and very precise calibration of Embozene(TM) Microspheres leads to superior clinical findings in the treatment of liver cancer," said Thomas A. Gordy, President and Chief Executive Officer, CeloNova Biosciences. "Embozene(TM) Microspheres, unlike other embolics, are precisely calibrated so that larger spheres do not prevent the deepest possible penetration of tumors. Patients with liver cancer treated in this new way can experience a longer life and a better quality of life."

About Embozene(TM) Microspheres

Embozene(TM) Microspheres are the first and only microspheres to be color-enhanced with a different color for each size for increased procedural safety, efficiency and visibility. They are also available in a wider range of sizes than any other spherical embolic on the market. CeloNova's Embozene(TM) Microspheres consist of a hydrogel core and an exterior shell made from Polyzene(R)-F, CeloNova's proprietary polymer which is known to be anti-inflammatory and bacterial-resistant. Four design features distinguish Embozene(TM) Microspheres from other spherical embolics: biocompatibility, precise calibration, stable suspension, and structural stability.

About CeloNova BioSciences, Inc.

Headquartered in Newnan, Georgia, CeloNova BioSciences, Inc., is a developer of novel medical devices that are enhanced by one of the Company's proprietary materials, Polyzene(R)-F, a highly lubricious, anti-thrombotic, anti-inflammatory, and bacterial-resistant making it an ideal surface treatment for implanted medical devices. The Company's current products include Embozene(TM) Color-Advanced Microspheres and the CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F. Both products are CE marked and Embozene(TM) Color Advanced microspheres have been approved by the US FDA. For more information, please visit www.celonova.com.

    CONTACT:
    Teresa Wilson
    CeloNova BioSciences, Inc.
    +1-678-895-6486
    +1-770-502-0304
    twilson@celonova.com


'/>"/>
SOURCE CeloNova BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Society of Interventional Radiology Applauds Reports Uterine Fibroid Embolization Recommendations
2. Chemoembolization Improving as Liver Cancer Treatment
3. Improved Cornea Surgery Technique Provides Enhanced Transplant Success
4. Stenting Techniques Vie in Branchpoint Lesions
5. Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques
6. Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology
7. Newly Published Article Details How PGS Techniques Directly Effect Successful Pregnancy Outcomes
8. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
11. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)...  Astute Medical, Inc., developer of biomarkers for better ... at the 2017 National Kidney Foundation (NKF) Spring ... April 22. Physicians will present data on two biomarkers, ... for acute kidney injury (AKI) during the management of ... Elevated levels of TIMP-2 and IGFBP-7 have been ...
(Date:4/18/2017)... , April 18, 2017 Research and ... the United States Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast ... ... molecular imaging equipment revenues as well as growth in the ... will provide value to market participants that design and manufacture ...
(Date:4/18/2017)... TAMPA, Fla. , April 18, 2017 WellCare ... Health Plans, Inc. (NYSE: WCG), announced today it will award ... Kentucky to reduce tobacco use and promote smoke-free ... Center for Smoke-Free Policy conference hosted by the University of ... first time WellCare, the state,s largest Medicaid managed care organization, ...
Breaking Medicine Technology:
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... MD (PRWEB) , ... April ... ... accreditation organization promoting quality-based imaging practices, is seeking candidates to serve on ... for diagnostic imaging. , “RadSite’s ultimate mission is improving image quality ...
(Date:4/21/2017)... ... , ... Westside Dental Associates and its owner, Dr. Les Latner, ... Dr. Latner has become one of the Los Angeles area’s premier dentists. “It’s been ... all their dental needs,” said Dr. Latner, who was recently named Chairperson of the ...
(Date:4/21/2017)... ... April 21, 2017 , ... During April 21-23, Super-Sod will join ... This festival offers entertainment for everyone — from the avid gardener to the landscape ... very high quality event held in a grand venue, and we are certainly looking ...
(Date:4/21/2017)... ... April 21, 2017 , ... Indiana Fiber Network, LLC (IFN), ... service to Tele-Media Solutions. IFN is delivering Multi-Gigabit data rates as an ... Solution’s protect transport with 3GB Dual Access Internet access now available in their ...
Breaking Medicine News(10 mins):